# Stroke Prevention in Nigeria 2 Trial

Study · id `cardio:ct-nct06526117` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06526117](<https://clinicaltrials.gov/study/NCT06526117>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06526117

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 220 participants.

## Technical summary

Registry record NCT06526117. Allocation not applicable; no masking; primary purpose prevention. Start 2024-08-05 (actual); primary completion 2029-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 220 participants (planned count; ClinicalTrials.gov record NCT06526117, source copy `cardio:ctgov-nct06526117-2026-03-05`, retrieved 2026-10-26)
- Started: 2024-08-05 (actual) (ClinicalTrials.gov record NCT06526117, source copy `cardio:ctgov-nct06526117-2026-03-05`, retrieved 2026-10-26)
- Primary completion: 2029-12-31 (anticipated) (ClinicalTrials.gov record NCT06526117, source copy `cardio:ctgov-nct06526117-2026-03-05`, retrieved 2026-10-26)
- Completion: 2030-06-30 (anticipated) (ClinicalTrials.gov record NCT06526117, source copy `cardio:ctgov-nct06526117-2026-03-05`, retrieved 2026-10-26)
- Countries: Nigeria (ClinicalTrials.gov record NCT06526117, source copy `cardio:ctgov-nct06526117-2026-03-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06526117-2026-03-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Stroke Prevention in Nigeria 2 Trial
- Acronym: SPRING-2
- Condition: Sickle Cell Disease
- Condition: Stroke
- Intervention (Drug): Hydroxyurea
- Lead sponsor: Vanderbilt University Medical Center
- Lead sponsor class: OTHER
- Collaborator: Aminu Kano Teaching Hospital
- Collaborator class: OTHER
- Collaborator: Murtala Muhammed Specialist Hospital
- Collaborator class: OTHER
- Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Vanderbilt University Medical Center (`cardio:org-vanderbilt-university-medical-center`)
- Registry lists this organization as a collaborator: Aminu Kano Teaching Hospital (`cardio:org-aminu-kano-teaching-hospital`)
- Registry lists this organization as a collaborator: Murtala Muhammed Specialist Hospital (`cardio:org-murtala-muhammed-specialist-hospital`)
- Registry lists this organization as a collaborator: National Institute of Neurological Disorders and Stroke (`cardio:ninds`)

## Provenance

Content hash: d01e7d62458977241a686ea227c57526297f1dcb3d97c1884975aa38365f7268
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
